Related references
Note: Only part of the references are listed.Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma
Rui Kuai et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer
Krassimira Todorova et al.
HORMONES & CANCER (2017)
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
Katyayani Tatiparti et al.
NANOMATERIALS (2017)
Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review
Ahmed M. Al-Abd et al.
JOURNAL OF ADVANCED RESEARCH (2017)
MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3
Yan Li et al.
CANCER LETTERS (2017)
miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas
Ju Cheol Son et al.
CANCER INFORMATICS (2017)
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles
Rui Kuai et al.
ACS NANO (2016)
miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC
Xinjuan Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells
Fangrong Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Antiangiogenic therapy in oncology: current status and future directions
Gordon C. Jayson et al.
LANCET (2016)
miR-204 Targets PERK and Regulates UPR Signaling and β-Cell Apoptosis
Guanlan Xu et al.
MOLECULAR ENDOCRINOLOGY (2016)
Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications
Jens B. Simonsen
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
Sherry Y. Wu et al.
NATURE COMMUNICATIONS (2016)
Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer
Ali Flores-Perez et al.
SCIENTIFIC REPORTS (2016)
Genome-wide identification of target genes for miR-204 and miR-211 identifies their proliferation stimulatory role in breast cancer cells
Hyunkyung Lee et al.
SCIENTIFIC REPORTS (2016)
High-density lipoproteins for therapeutic delivery systems
R. Kannan Mutharasan et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Targeting SR- BI for Cancer Diagnostics, Imaging and Therapy
Maneesha A. Rajora et al.
FRONTIERS IN PHARMACOLOGY (2016)
Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
Linda K. Mooberry et al.
FRONTIERS IN PHARMACOLOGY (2016)
Future options of anti-angiogenic cancer therapy
Yihai Cao
CHINESE JOURNAL OF CANCER (2016)
MicroRNAs are essential for differentiation of the retinal pigmented epithelium and maturation of adjacent photoreceptors
Reut Ohana et al.
DEVELOPMENT (2015)
Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro
Hongliang Yan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
HDL as a drug and nucleic acid delivery vehicle
Andras G. Lacko et al.
FRONTIERS IN PHARMACOLOGY (2015)
miRNA-directed regulation of VEGF in tilapia under hypoxia condition
Yan Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
A Critical Role for Thioredoxin-Interacting Protein in Diabetes-Related Impairment of Angiogenesis
Louise L. Dunn et al.
DIABETES (2014)
Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-Convergence on axonal guidance
Sanne S. Kaalund et al.
EPILEPSIA (2014)
Thematic Review Series: High Density Lipoprotein Structure, Function, and Metabolism HDL and cholesterol: life after the divorce?
Kasey C. Vickers et al.
JOURNAL OF LIPID RESEARCH (2014)
Identification and consequences of miRNA-target interactions - beyond repression of gene expression
Jean Hausser et al.
NATURE REVIEWS GENETICS (2014)
Current understanding of the thrombospondin-1 interactome
Andrea Resovi et al.
MATRIX BIOLOGY (2014)
MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer
Wei Wang et al.
ONCOLOGY REPORTS (2014)
The role of microRNAs in human breast cancer progression
WenCheng Zhang et al.
TUMOR BIOLOGY (2014)
Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia
Bo Yu et al.
BLOOD (2013)
miR-204 Inhibits Epithelial to Mesenchymal Transition by Targeting Slug in Intrahepatic Cholangiocarcinoma Cells
Ying-he Qiu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Role of Focal Adhesion Kinase in Regulating YB-1-Mediated Paclitaxel Resistance in Ovarian Cancer
Yu Kang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Tumour angiogenesis regulation by the miR-200 family
Chad V. Pecot et al.
NATURE COMMUNICATIONS (2013)
CD133 expression associated with poor prognosis in ovarian cancer
Jing Zhang et al.
MODERN PATHOLOGY (2012)
Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization
J. Saadi Imam et al.
PLOS ONE (2012)
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and-2
Patrick R. Lawler et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Role for miR-204 in human pulmonary arterial hypertension
Audrey Courboulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Kasey C. Vickers et al.
NATURE CELL BIOLOGY (2011)
Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
Mian M. K. Shahzad et al.
NEOPLASIA (2011)
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Gang Niu et al.
CURRENT DRUG TARGETS (2010)
MicroRNA: Biogenesis, Function and Role in Cancer
Leigh-Ann MacFarlane et al.
CURRENT GENOMICS (2010)
The Angiogenic Inhibitor Long Pentraxin PTX3 Forms an Asymmetric Octamer with Two Binding Sites for FGF2
Antonio Inforzato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
J Lawler
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Share Paper
